Search
Powered By HealthLine
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

First Human Tests of Hepatitis C Vaccine Begin


Related Encyclopedia
 border=
Acne
Alagille Syndrome
Appendicitis
Arteriohepatic Dysplasia
More...

Related Animations
 border=
Dental Cavities
Hepatitis
More...

Related Healthscout Videos
 border=
Coming Around: Coma Breakthroughs
Baby Steps: Fertility Findings
Saving Infants from Killer Bacteria: NEC
The New Tooth Fairy: Banking Dental Stem Cells
More...

Related Drug Information
 border=
Adderal XR
Concerta
Strattera
More...

Related News Articles
 border=
Best Friend Benefits Child's Mind, Body, Study Finds
Kindergartners Who Can Pay Attention May Reap Benefits Later
Most Teens Who Self-Harm Are Not Evaluated for Mental Health in ER
HIV Severity, Treatment Unrelated to Kids' Mental Woes: Study
More...


Page:  << Prev | 1 | 2

Blood samples will be taken periodically from the volunteers getting the vaccine to test for antibody and immune cell levels, Belshe says. If those responses are satisfactory, the next step will be a larger study, involving several hundred healthy volunteers, to get broader measures of safety and immune system response. A trial of the vaccine's effectiveness in protecting against hepatitis C infection would begin only if that study succeeds, he says.

Candidates for the effectiveness trial would be persons at high risk of hepatitis C infection, such as health-care workers and drug users who might share infected needles, Belshe says. Changes in the vaccine are expected before such a trial would begin.

Text Continues Below



"This vaccine is not expected to be the final vaccine," Belshe says. "But it is an important step along the way."

He hopes the hepatitis C vaccine program will follow the path of an earlier program that produced an effective vaccine against the hepatitis B virus. "That program also started with safety tests on healthy individuals, then moved to trials with people at high risk. "The vaccine was so effective and so safe that it now is used routinely," Belshe says.

"This is really the first candidate for a hepatitis C vaccine for humans in the United States," says Di Bisceglie. "We have many steps to go before we have a successful vaccine."

More information

Learn about hepatitis C at the Washington State Department of Health (www.doh.wa.gov) or the U.S. Centers for Disease Control and Prevention ( www.cdc.gov).

Page:  << Prev | 1 | 2

Copyright © 2003 ScoutNews, LLC. All rights reserved.
Last updated 11/17/2003

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake




SOURCES: Robert B. Belshe, M.D., director, Center for Vaccine Development, Saint Louis University School of Medicine; Adrian M. Di Bisceglie, M.D., chief, hepatology, Saint Louis University School of Medicine, St. Louis


HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2012. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire